NRX Pharmaceuticals- Warrants (24/05/2026) OverviewNRX Pharmaceuticals- Warrants (24/05/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NRXPW.
Quarterly EBIT
-$4.74M
↑ 13.97% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$32.81M
↓ 33.03% YoY
Trailing 12 months ending Mar 31, 2026